Drugmakers have been bracing for levies and sought to get ahead of them with pledges to invest billions more on domestic ...
Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc (NASDAQ: AMGN) ...
Discover how Trump’s 100% drug tariff impacts NVO, SNY, and AZN stocks. Click for which pharma giants face the most risk—and ...
Beginning Oct. 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports unless manufacturers are ...
Shingrix GSK's vaccine Shingrix, used to prevent shingles, contributed 3.36 billion pounds ($4.50 billion) in sales in 2024. Its ingredients are manufactured in Belgium according to product labelling ...
(Reuters) -Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump ...
Global pharmaceutical companies are significantly boosting their U.S. manufacturing investments in response to potential ...
U.S. President Donald Trump on Thursday unveiled a 100% tariff on imports of branded drugs from October 1, unless their ...
European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will ...
The industry-based tariffs offer potentially more durability than the country-level levies Trump imposed under the ...
The potential of AI to analyse vast quantities of data in a relatively short time frame makes its application to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results